| Literature DB >> 33946859 |
Chadia Mekki1, Abdel Aissat1,2, Véronique Mirlesse3,4, Sophie Mayer Lacrosniere5, Elsa Eche3, Annick Le Floch1, Sandra Whalen6, Cecile Prud'Homme6, Christelle Remus7, Benoit Funalot1,2,7, Vanina Castaigne8, Pascale Fanen1,2, Alix de Becdelièvre1,2.
Abstract
In families without a Cystic Fibrosis (CF) history, fetal ultrasound bowel abnormalities can unexpectedly reveal the disease. Isolated or in association, the signs can be fetal bowel hyperechogenicity, intestinal loop dilatation and non-visualization of fetal gallbladder. In these cases, search for CF transmembrane conductance regulator (CFTR) gene mutations is part of the recommended diagnostic practices, with a search for frequent mutations according to ethnicity, and, in case of the triad of signs, with an exhaustive study of the gene. However, the molecular diagnosis remains a challenge in populations without well-known frequent pathogenic variants. We present a multiethnic cohort of 108 pregnancies with fetal bowel abnormalities in which the parents benefited from an exhaustive study of the CFTR gene. We describe the new homozygous p.Cys1410* mutation in a fetus of African origin. We did not observe the most frequent p.Phe508del mutation in our cohort but evidenced variants undetected by our frequent mutations kit. Thanks to the progress of sequencing techniques and despite the difficulties of interpretation occasionally encountered, we discuss the need to carry out a comprehensive CFTR study in all patients in case of fetal bowel abnormalities.Entities:
Keywords: Africa; CFTR; Cystic Fibrosis (CF); echogenic bowel; mutation; non-Caucasian; non-visualization of fetal gallbladder (NVFGB); prenatal
Year: 2021 PMID: 33946859 DOI: 10.3390/genes12050670
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096